BioUtah to Attend the J.P. Morgan 43rd Annual Healthcare Conference
SALT LAKE CITY -– January 9, 2025 – BioUtah, the trade association, common voice, and flag bearer for Utah’s life sciences industry, today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16, 2025. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the association, representing the more than 2,000 life sciences companies across the state. Utah boasts strengths in medical device manufacturing, diagnostics, biotechnology, pharmaceuticals, and digital health.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- BioUtah, the trade association, common voice, and flag bearer for Utah’s life sciences industry, will participate in the 2025 J.P. Morgan 43rd Annual Healthcare Conference. BioUtah to co-host an RSVP-required reception on Sunday night, January 12, 2025
- A number of Utah companies developing new treatments and cutting-edge medical technologies will be presenting at the conference and other events.
- Utah consistently ranks in the top three states for growth in the life sciences with more than 2,000 companies engaged in medical device manufacturing, diagnostics, biotechnology, pharmaceuticals, and digital health.
Click image above to view full announcement.
Contacts:
Denise Bell
[email protected]
Source: BioUtah
Distributed by: Reportable, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HTX Research Examines U.S. AI Equities: Technology Remains Early, While Capital Expenditure and Valuations Have Entered the Late Cycle
- Alibaba Group Announced Proposed Placing of New Shares in Hong Kong
- Last Chance to Join the Apeing Whitelist Before This Upcoming Crypto Coin Rivals Monero and Ethereum
Create E-mail Alert Related Categories
Press Releases, ReportableRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share